Palatin Technologies Inc. PTN

ASE: PTN | ISIN: US6960774031   14/11/2024
1,070 USD (-10,08%)
(-10,08%)   14/11/2024

17 mei 2022 · Palatin Reports Third Quarter Fiscal Year 2022 Financial Results and Provides Corporate Update · Persbericht

12 mei 2022 · Palatin Announces $15 Million Private Placement of Convertible Redeemable Preferred Stock · Persbericht

11 mei 2022 · Palatin to Report Third Quarter, Fiscal Year 2022 Results; Teleconference and Webcast to be held on May 17, 2022 · Persbericht

2 mei 2022 · Palatin to Present at the Association for Research in Vision and Ophthalmology (ARVO) 2022 Annual Conference · Persbericht

21 april 2022 · Palatin to Present at Eyecelerator @ American Society of Cataract and Refractive Surgery (ASCRS) 2022 · Persbericht

3 maart 2022 · Palatin Hosting Key Opinion Leader Webinar on Dry Eye Disease · Persbericht

15 februari 2022 · Palatin Reports Second Quarter Fiscal Year 2022 Financial Results and Provides Corporate Update · Persbericht

10 februari 2022 · Palatin to Report Second Quarter, Fiscal Year 2022 Results; Teleconference and Webcast to be held on February 15, 2022 · Persbericht

21 januari 2022 · Palatin Announces Presentation at the 2022 Crohn's and Colitis Congress · Persbericht

7 januari 2022 · Palatin to Present at H.C. Wainwright BioConnect Conference · Persbericht

28 december 2021 · Palatin Announces Initiation of Pivotal Phase 3 PL9643 MELODY-1 Clinical Trial in Patients with Dry Eye Disease · Persbericht

30 november 2021 · Notice of Allowance Issued for Method of Treating Cytokine Storm Using Melanocortin-Specific Peptide · Persbericht

15 november 2021 · Palatin Reports First Quarter Fiscal Year 2022 Results and Provides Corporate Update · Persbericht

10 november 2021 · Palatin to Report First Quarter, Fiscal Year 2022 Results; Teleconference and Webcast to be held on November 15, 2021 · Persbericht

22 oktober 2021 · Palatin Awarded "Top 10 Poster" Designation at the American Society of Retina Specialists (ASRS) 2021 Annual Meeting · Persbericht

29 september 2021 · Palatin Reports Fourth Quarter and Full Year Fiscal Year 2021 Financial Results and Provides Corporate Update · Persbericht

27 september 2021 · Palatin Announces Presentation of Positive Protective Effects of PL8331 and PL9654 on Retinal Inflammation at the 2021 American Society of Retina Specialists (ASRS) Annual Meeting · Persbericht

24 september 2021 · Palatin To Report Fourth Quarter And Fiscal Year End 2021 Results; Teleconference And Webcast To Be Held On September 29, 2021 · Persbericht

15 september 2021 · Palatin to Present Peptides Platform at the TIDES USA Conference · Persbericht

13 september 2021 · Palatin to Participate in H.C. Wainwright 23rd Annual Global Investment Virtual Conference · Persbericht

Mijn selecties